Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease

5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine-2,4-dione for treating nonalcoholic fatty liver disease

US Patent 11938122 · Granted Mar 26, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2024
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2024
Isoquinoline compounds, methods for their preparation, and therapeutic uses ther2022
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors2019
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors2019
2,4-thiazolidinedione derivatives in the treatment of central nervous system dis2019
2,4-thiazolidinedione derivatives in the treatment of central nervous system dis2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors2018
Lysine demethylase inhibitors for myeloproliferative disorders2018
2,4-thiazolidinedione derivatives in the treatment of central nervous system dis2017
2,4-thiazolidinedione derivatives in the treatment of central nervous system dis2017